期刊文献+

人性化护理在腹腔镜手术联合奥美拉唑治疗胃癌患者术后康复中的应用研究 被引量:7

Application of Humanistic Nursing in Postoperative Rehabilitation of Patients with Gastric Cancer Treated by Omeprazole Combined with Laparoscopic Surgery
下载PDF
导出
摘要 目的探讨人性化护理在腹腔镜手术联合奥美拉唑联治疗胃癌患者术后康复中的应用研究。方法选取我院收治的接受奥美拉唑联合腹腔镜胃癌手术治疗的患者98例,按照随机数字法分为两组,对照组应用奥美拉唑联合腹腔镜手术进行治疗并配合常规护理,观察组应用奥美拉唑联合腹腔镜手术进行治疗并配合人性化护理。分析两组患者干预后焦虑、抑郁评分、生活质量评分、相关治疗指标以及满意度。结果干预后,观察组焦虑、抑郁评分、生活质量评分、肛门排气时间、住院时间以及护理满意度均显著优于对照组(P<0.05)。结论对接受奥美拉唑联合腹腔镜手术治疗的患者实施人性化护理的效果理想,临床上应当进一步推广应用。 Objective To explore the application of humanistic nursing in postoperative rehabilitation of patients with gastric cancer treated by omeprazole combined with laparoscopic surgery.Methods From May 2016 to March 2018,98 patients with gastric cancer who received omeprazole combined with laparoscopic surgery were randomly divided into two groups.The control group was treated with omeprazole combined with laparoscopic surgery,and routine nursing.The observation group was treated with omeprazole combined with laparoscopic surgery,and humanistic nursing.After intervention,the anxiety and depression score,quality of life score,related treatment indicators and satisfaction were analyzed and compared.Results After treatment,the observation group got higher effective rate than the control group(P<0.05).The scores of anxiety and depression in the observation group were lower than those of the control group(P<0.05).Compared with before treatment,the scores of quality of life were decreased in both groups after treatment,but the scores were significantly lower in the observation group than in the control group after treatment(P<0.05).The anal exhaust time and hospitalization time in observation group were shorter than in control group(P<0.05).Patients in observation group had higher satisfaction degree to nursing than those in the control group(P<0.05).Conclusion For patients receiving omeprazole combined with laparoscopic surgery,humanistic nursing intervention had good effect and should be further popularized and applied in clinic.
作者 陈婕 马君俊 刘晓敏 张惠雯 倪宇婕 CHEN Jie;MA Junjun;LIU Xiaomin;ZHANG Huiwen;NI Yujie(Department of Gastroenterology,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai,200023,China)
出处 《肿瘤药学》 CAS 2019年第1期164-167,共4页 Anti-Tumor Pharmacy
关键词 人性化护理 奥美拉唑 腹腔镜手术 胃癌 术后康复 Humanistic nursing Omeprazole Laparoscopic surgery Gastric cancer Postoperative rehabilitation
  • 相关文献

参考文献5

二级参考文献42

  • 1Ming Lu,Jing Gao, Xi-cheng Wang, Lin Shen.Expressions of Thymidylate Synthase, Thymidine Phosphorylase, Class Ⅲ β-tubulin, and Excision Repair Cross-complementing Group 1 Predict Response in Advanced Gastric Cancer Patients Receiving Capecitabine Plus Paclitaxel or Cisplatin[J].Chinese Journal of Cancer Research,2011,23(4):288-294. 被引量:22
  • 2刘小颖,朱姜华,王沛玉,王薇,钱朝霞,吴新民.不同麻醉用药与不同麻醉方法对术中患者应激反应的影响[J].中华医学杂志,2007,87(15):1025-1029. 被引量:39
  • 3江志伟,黎介寿,汪志明,李宁,柳欣欣,李伟彦,朱四海,刁艳青,佴永军,黄小静.胃癌患者应用加速康复外科治疗的安全性及有效性研究[J].中华外科杂志,2007,45(19):1314-1317. 被引量:242
  • 4Mizoshita T, Kataoka H, Klbota E, et ah Gastric Phenotype signet-ring cell carcinoma a o-f the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil [J Int J Clin Oncol, 2008, 13(4): 373-376.
  • 5MacLellan SJ, MacKay H J, Ringash J, et al. Laparoscopic gastrectomy for patients with advanced gastric cancer pro- duces oncologic outcomes similar to those for open resection [J Surg Endosc, 2012, 26(7): 1813-1821. doi: 10. 1007/ s00464-011-2118-y,.
  • 6Cunningham D, Starling N, Rao S, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer [J]. N Engl J Med, 2008, 358(1): 36-46.
  • 7Koizumi W, Narahara H, Hara T, et al. S-1 plus eisplatin versus S-1 alone for fi1t-line treatment of advanced gastric cancer(SPIRITS trial): a Phase HI trial [J Lancet Oncol, 2008, 9(3): 215-221.
  • 8Koizumi W, Takiuchi H, Yamada Y, el al. Phase II stady of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer(G-SOX study)[Jl. Arm Oncol, 2010, 21(5): 1001-1005.
  • 9Narahara H, Iishi H, Imamura H, et al. Randomized Phase m study comparing the efficacy and safety of irinotecan Plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer(study GC0301/TOP-002 ) [J Gastric Can- cer, 2011, 14(1): 72-80.
  • 10Sato Y, Takayama T, Sagawa T, et al. Phase II study of S-b, docetaxel and cisplatin combination chemotherapy in pa- tients with unresectable metastatic gastric cancer [J]. Cancer Chemother Pharmacol, 2010, 66(4): 721-728.

共引文献114

同被引文献61

引证文献7

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部